Pricing Log in Create free account

Cybin Inc. (HELP) vs Kura Oncology, Inc. (KURA)

Cybin Inc. and Kura Oncology, Inc. are both Biotechnology companies. Cybin Inc. and Kura Oncology, Inc. are of similar size ($613.0M and $604.9M). Cybin Inc. has the higher net margin (0.00% vs −384.3%) and the lower return on invested capital (−137.9% vs 0.00%). Across the 14 metrics below, Cybin Inc. leads on 9 and Kura Oncology, Inc. on 5.

Valuation

Metric HELP KURA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 8.31 9.40
P/B 1.94 13.25 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.71 9.02
Earnings yield (47.34%) (46.68%) (32.88%)
Free cash flow yield (30.48%) (18.30%) (23.13%)

Profitability

Metric HELP KURA Biotechnology median
Gross margin 0.00% 99.35% 68.51%
Operating margin 0.00% (411.90%) 0.00%
Net margin 0.00% (384.30%) 0.00%
Free cash flow margin 0.00% (152.06%) 0.00%
Return on equity (86.94%) (167.71%) (51.96%)
Return on assets (72.78%) (46.73%) (46.06%)
Return on invested capital (137.88%) 0.00% 0.00%

Growth

Metric HELP KURA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (5.72%) (57.43%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HELP KURA Biotechnology median
Debt to equity 0.00 0.20 0.00
Current ratio 10.97 4.73 4.97
Net debt to EBITDA 1.10 2.11 1.01

Dividend

Metric HELP KURA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HELP KURA Biotechnology median
Market cap 612.97m 604.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack